| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |